These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24999092)

  • 1. Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance.
    Jing H; Zhang G; Meng L; Meng Q; Mo H; Tai Y
    Sci Rep; 2014 Jul; 4():5503. PubMed ID: 24999092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis.
    Su B; Luo T; Zhu J; Fu J; Zhao X; Chen L; Zhang H; Ren Y; Yu L; Yang X; Wu M; Feng G; Li S; Chen Y; Wang H
    Hepatology; 2015 Feb; 61(2):585-97. PubMed ID: 25294684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma.
    Umemura A; Itoh Y; Itoh K; Yamaguchi K; Nakajima T; Higashitsuji H; Onoue H; Fukumoto M; Okanoue T; Fujita J
    Hepatology; 2008 Feb; 47(2):493-502. PubMed ID: 18161051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.
    Sakurai T; Yada N; Hagiwara S; Arizumi T; Minaga K; Kamata K; Takenaka M; Minami Y; Watanabe T; Nishida N; Kudo M
    Cancer Sci; 2017 Oct; 108(10):1996-2003. PubMed ID: 28777492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.
    Song X; Wang J; Zheng T; Song R; Liang Y; Bhatta N; Yin D; Pan S; Liu J; Jiang H; Liu L
    Mol Cancer; 2013 Oct; 12(1):114. PubMed ID: 24093956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance.
    Fu XY; Wang HY; Tan L; Liu SQ; Cao HF; Wu MC
    World J Gastroenterol; 2002 Aug; 8(4):638-43. PubMed ID: 12174370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
    Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
    Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Microcystin-LR Exposure Induces Hepatocarcinogenesis via Increased Gankyrin in Vitro and in Vivo.
    He L; Huang Y; Guo Q; Zeng H; Zheng C; Wang J; Chen JA; Wang L; Shu W
    Cell Physiol Biochem; 2018; 49(4):1420-1430. PubMed ID: 30205410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin.
    Xu X; Lou Y; Tang J; Teng Y; Zhang Z; Yin Y; Zhuo H; Tan Z
    Cell Death Dis; 2019 Jan; 10(2):86. PubMed ID: 30692513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.
    Zhao X; Fu J; Xu A; Yu L; Zhu J; Dai R; Su B; Luo T; Li N; Qin W; Wang B; Jiang J; Li S; Chen Y; Wang H
    Cell Death Dis; 2015 May; 6(5):e1751. PubMed ID: 25950481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
    Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
    Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation.
    Huang SJ; Cheng CL; Chen JR; Gong HY; Liu W; Wu JL
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1052-1058. PubMed ID: 28668389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
    Han J; Wang F; Lan Y; Wang J; Nie C; Liang Y; Song R; Zheng T; Pan S; Pei T; Xie C; Yang G; Liu X; Zhu M; Wang Y; Liu Y; Meng F; Cui Y; Zhang B; Liu Y; Meng X; Zhang J; Liu L
    Oncogene; 2019 Jan; 38(3):406-420. PubMed ID: 30115976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.
    Jiang Y; Iakova P; Jin J; Sullivan E; Sharin V; Hong IH; Anakk S; Mayor A; Darlington G; Finegold M; Moore D; Timchenko NA
    Hepatology; 2013 Mar; 57(3):1098-106. PubMed ID: 23172628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Gankyrin oncoprotein overexpression with histopathological grade in prostate cancer.
    Riahi MM; Sistani NS; Zamani P; Abnous K; Jamialahmadi K
    Neoplasma; 2017; 64(5):732-737. PubMed ID: 28592125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gankyrin is frequently overexpressed in cervical high grade disease and is associated with cervical carcinogenesis and metastasis.
    Liu Y; Zhang J; Qian W; Dong Y; Yang Y; Liu Z; Feng Y; Ma D; Zhang Z; Wu S
    PLoS One; 2014; 9(4):e95043. PubMed ID: 24751719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.